How to buy Augmedix stock (Augmedix)

Augmedix, a medical documentation company, is expected to conduct a public offering of its stock. The deal is contingent upon the approval of its application for listing on the Nasdaq.

The stock is currently traded on the Over-the-Counter Market under the ticker symbol "AUGX," and if approved, it will trade on the Nasdaq under the same symbol.

Our top picks for where to buy Augmedix stock

Buy Augmedix stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Augmedix stock price (NASDAQ: AUGX)

Use our graph to track the performance of AUGX stocks over time.

Augmedix shares at a glance

• Key figures

Information last updated 2024-12-01.

52-week range	$0.73 - $6.25
50-day moving average more info button	$2.30
200-day moving average more info button	$2.87
Wall St. target price	$2.92
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.47

Is it a good time to buy Augmedix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Augmedix financials

Revenue TTM	$51.6 million
Gross profit TTM	$14 million
Return on assets TTM	-30.61%
Return on equity TTM	-329.78%
Profit margin	-46.23%
Book value	$0.21
Market Capitalization more info button	$116.2 million

TTM: trailing 12 months

Augmedix share dividends

We're not expecting Augmedix to pay a dividend over the next 12 months.

You may also wish to consider:

• Cerner (CERN.US) (1.14% forward annual dividend yield)

Augmedix share price volatility

Over the last 12 months, Augmedix's shares have ranged in value from as little as $0.73 up to $6.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Augmedix's is -0.19. This would suggest that Augmedix's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Augmedix has bucked the trend.

To put Augmedix's beta into context you can compare it against those of similar companies.

• CareCloud (MTBC.US): 0.7918
• Cerner (CERN.US): 0.7613

Augmedix overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was formerly known as Malo Holdings Corporation and changed its name to Augmedix, Inc. in October 2020.

Frequently asked questions

null
What percentage of Augmedix is owned by insiders or institutions?
Currently 1.502% of Augmedix shares are held by insiders and 84.783% by institutions. How many people work for Augmedix?
Latest data suggests 1,430 work at Augmedix. When does the fiscal year end for Augmedix?
Augmedix's fiscal year ends in December. Where is Augmedix based?
Augmedix's address is: 111 Sutter Street, San Francisco, CA, United States, 94104 What is Augmedix's ISIN number?
Augmedix's international securities identification number is: US05105P1075